Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: Radiopharmacy

Design and validation of a semi-automated sodium[18F]fluoride formulation system

Michael Nader, Michael Schubert and Dirk Becker
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 136P;
Michael Nader
1Argos Zyklotron GmbH, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schubert
1Argos Zyklotron GmbH, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Becker
1Argos Zyklotron GmbH, Linz, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

464

Objectives: It has been the aim of the present work to develop and validate a GMP compliant semi-automated formulation module to produce sodium[18F]fluoride for injection. Methods: A semi-automated formulation and purification system has been developed operated by a time triggered sequential control. During the production process raw sodium[18F]fluoride from the cyclotron “silver” target is trapped on an anion exchange cartridge, cleaned with sterile water and eluted with sterile saline 0.9 % solution. The production process is followed by a semi-automated cleaning sequence. The process validation of the system consisted of the validation of the purification and trapping efficacy as well as of the cleaning process. Results: A production module has been developed which represents a closed fully GMP- compliant production system. In course of the process validation it could be proofed that just 5.6 x 10-4 % of the trapped target radioactivity was left on the anion exchange cartridge after the final elution. Furthermore, the efficacy of the purification step has been evaluated by the determination of the amount long living isotopes of the raw target liquid, left on the cartridge, in the final product as well as in the waste liquid. The gamma spectroscopy of the final product showed that the concentration of long-living isotopes could be reduced by 97 % compared to the raw product with means of the applied purification process. An ICP-OES analysis of the final product could not detect any traces of silver based on a limit of detection of 0.1 ppm. The validation of the cleaning procedure of the synthesis module after the production showed that the time and the substance employed for cleaning are appropriate and leave no residue that could impair the following synthesis. The microbiological cleaning validation also neither showed any endotoxines nor any microbiological recount. Conclusions: A GMP compliant semi-automated formulation module for the production of sodium[18F]fluoride for injection has been developed. The process validation and evaluation of the system confirmed a high purification efficacy and suitability.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Design and validation of a semi-automated sodium[18F]fluoride formulation system
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Design and validation of a semi-automated sodium[18F]fluoride formulation system
Michael Nader, Michael Schubert, Dirk Becker
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 136P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Design and validation of a semi-automated sodium[18F]fluoride formulation system
Michael Nader, Michael Schubert, Dirk Becker
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 136P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: Radiopharmacy

  • Automated manufacturing of clinical-grade 177Lu- labeling DOTA0-Tyr3-octreotate using SmarTrace
  • The production of high specific activity Cu-64 as measured by ion chromatography
  • Ethanol and LPS stimulation of 18F FHBG uptake by lung and heart of NF Kappa B TK transgenic mice
Show more Radiopharmaceutical Chemistry: Radiopharmacy

PET

  • Analyzing common reasons and demographics among missed PET appointments
  • Clinical Comparison: [F-18]Fluciclovine & [F-18]Piflufolastat
  • Comparing PSA and SUVs in PSMA Positive Prostate Cancer for Patients with and without Prostatectomy
Show more PET

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire